author-photo

Elimika Pfuma

Center for Drug Evaluation and Research

1

Papers

47

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma.

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (47)